hydroxyl-end-functional macroraft agent (Boston Therapeutics)
90
Structured Review
Boston Therapeutics
hydroxyl-end-functional macroraft agent
Hydroxyl End Functional Macroraft Agent, supplied by Boston Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hydroxyl-end-functional+macroraft+agent/hydroxyl+end+functional+macroraft+agent/10__1021_slash_acs__macromol__8b02146-140-3-9
Average 90 stars, based on 1 article reviews
Hydroxyl End Functional Macroraft Agent, supplied by Boston Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hydroxyl-end-functional+macroraft+agent/hydroxyl+end+functional+macroraft+agent/10__1021_slash_acs__macromol__8b02146-140-3-9
Average 90 stars, based on 1 article reviews
hydroxyl-end-functional macroraft agent - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Nonmigratory Poly(vinyl chloride)-block-polycaprolactone Plasticizers and Compatibilizers Prepared by Sequential RAFT and Ring-Opening Polymerization (RAFT-T̵-ROP) Article Snippet: Well-defined nonmigrating polymeric plasticizers, poly(vinyl chloride)-block-polycaprolactone (PVC-b-PCL), were synthesized by sequential reversible addition−fragmentation chain transfer (RAFT) polymerization and ring-opening polymerization (ROP) with 2-hydroxyethyl 2-(ethoxycarbonothioylthio)propanoate (HECP) as RAFT agent and incipient initiator for ROP of ε-caprolactone (CL, oxepan-2-one).. Kinetic experiments demonstrated that HECP provided good control in RAFT polymerization of vinyl chloride (VC) with dispersity (Đ) ∼ 1.2 for 3400 < Mn < 11000.. Chain extension experiments with VC and vinyl acetate proved the high end-group fidelity of the macroRAFT agent formed. |